$GSK News

GSK plc (GSK) Discusses Bepirovirsen Phase III Data and Advances in Hepatitis B Treatment - Slideshow

GSK Announces UK's NICE Issues Guidance Recommending Nucala For Use On The NHS For Uncontrolled COPD Patients

GSK: Improved Prospects After Correction

GSK’s Expanded Arexvy Label And Deals Add Context To Valuation Gap

Here's Why GSK (GSK) is a Strong Value Stock

Why Gilead Sciences Is Now A Hold (Rating Upgrade)

Wave Life Sciences: 'Strong Buy' On DMD NDA Filing WVE-N531 And Released AATD Data

GSK PLC-SPON ADR (NYSE:GSK) Passes Quality-Focused Caviar Cruise Stock Screener with Strong Profitability and Cash Flow

Benlysta Sales Forecast and Market Size Analysis Report 2026-2034 with Focus on United States, Germany, France, Italy, Spain, United Kingdom, and Japan

GSK China Hepatitis B Alliance Puts Bepirovirsen And Valuation In Focus

Ambirix (GlaxoSmithKline) Market Research Report 2026: Epidemiology, Pipeline Analysis, Insights & Forecasts, 2020-2025, 2025-2030F, 2035F

Julie Bowen and Ty Burrell team up with GSK to raise awareness about meningitis risks for teens and young adults

GSK's (LON:GSK) Performance Is Even Better Than Its Earnings Suggest

Vaccine Star Shingrix Lifts GSK, But Weak Segments Raise Eyebrows

GSK Reaffirms 2026 Guidance With 3%-5% Turnover Growth And 7%-9% Core EPS Growth, Eyes £40B+ Sales By 2031

GSK Q1 Adj. EPS $1.25 Beats $1.17 Estimate, Sales $10.222B Beat $10.190B Estimate

SBIO: Leaning Into Drug Discovery And Medical Breakthroughs

GSK's Bepirovirsen Receives FDA Priority Review And Breakthrough Therapy Designation For Chronic Hepatitis B With PDUFA Date Of October 26

Gilead Sciences: Why I'm Tempted To Sell Ahead Of Q1 Earnings - But Won't

Wall Street Breakfast Podcast: Flight Cuts Deepen On Fuel Shock